About 30 results found for searched term "Prostaglandin Receptor" (0.098 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5401 | Prostaglandin E1 (Alprostadil) | Prostaglandin Receptor |
| Alprostadil; PGE1 | ||
| Prostaglandin E1 (Alprostadil) is a prostanoid receptor ligand, which induces vasodilation and inhibits platelet aggregation. Prostaglandin E1 can be used as a vasodilator for the research of peripheral vascular diseases. | ||
| M5729 | Latanoprost | Prostaglandin Receptor |
| Xalatan, PhXA41, PHXA-41 | ||
| Latanoprost is a prostaglandin F2α analog as well as a prostaglandin-like selective FP receptor agonist with lipophilic and corneal penetrating properties. In addition, Latanoprost also increases ocular fluid outflow, thereby reducing intraocular pressure, and may be used in studies related to glaucoma. | ||
| M5929 | Prostaglandin E2 | Prostaglandin Receptor |
| Dinoprostone; PGE2 | ||
| Prostaglandin E2 is a vasodilator isolated from prostate gland secretion, working by binding and activating the prostaglandin E2 receptor. | ||
| M6436 | AMG 853 | Others |
| AMG 853 is a potent dual CRTH2 and prostaglandin D 2 (PGD 2) receptor antagonist. | ||
| M6714 | Epoprostenol sodium | Prostaglandin Receptor |
| Epoprostenol is an endogenous steroid and a selective agonist of the prostaglandin I2 receptor (PI2R) that inhibits platelet aggregation and induces vasodilation. It can be used in studies related to pulmonary hypertension. | ||
| M7426 | Travoprost | Prostaglandin Receptor |
| Fluprostenol isopropyl ester; AL6221; Flu-Ipr | ||
| Travoprost is a potent and selective FP prostaglandin receptor agonist. | ||
| M7439 | U-46619 | Others |
| 9,11-Methanoepoxy PGH2 | ||
| U-46619 is a pGH2 (TXA2) analog that is a potent and stable thromboxane A2 (TP) receptor agonist (EC50 = 0.035 μM). U-46619 potently stimulates TP receptor-mediated, but not other prostaglandin receptor-mediated responses in various in vitro preparations. | ||
| M7595 | AL-8810 | Others |
| AL-8810 is a novel prostaglandin F2α analog; selective FP prostanoid receptor antagonist. | ||
| M8111 | PF-06748962 | Others |
| PF-06748962 is a potent and selective lactam-based prostaglandin EP3 receptor antagonist. | ||
| M8120 | PF-04217329 | Others |
| PF-04217329 is a selective and potent prostaglandin EP2 receptor agonist. | ||
| M8780 | ONO-AE3-208 | Prostaglandin Receptor |
| AE 3-208 | ||
| ONO-AE3-208 is an orally active prostaglandin E2 receptor 4 (EP4)-selective antagonist (Ki in nM = 1. | ||
| M8900 | TG6-10-1 | 5-HT Receptor |
| TP-6101 | ||
| TG6-10-1 is a potent and selective antagonist for the prostaglandin E2 receptor subtype EP2. | ||
| M8971 | Grapiprant | Prostaglandin Receptor |
| CJ-023423; RQ-00000007; AAT-007 | ||
| Grapiprant is a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties. | ||
| M9232 | PF-04418948 | Prostaglandin Receptor |
| PF-04418948 is a novel, potent and selective prostaglandin EP2 receptor antagonist with IC50 of 16 nM. | ||
| M10579 | Dinoprost tromethamine | Prostaglandin Receptor |
| Dinolytic; PGF2-alpha tham; Zinoprost; Prostin F2 alpha | ||
| Dinoprost tromethamine (Prostaglandin F2α tromethamine) is an orally active, potent prostaglandin F (PGF) receptor (FP receptor) agonist. | ||
| M10632 | AM211 | Prostaglandin Receptor |
| AM-211; AM211 free acid | ||
| AM-211 is a novel and potent antagonist of the prostaglandin D2 receptor type 2, with IC50s of 4.9 nM, 7.8 nM, 4.9 nM, 10.4 nM for human, mouse, guinea pig, and rat DP2, respectively. | ||
| M10791 | BAY-1316957 | Prostaglandin Receptor |
| BAY-1316957 is a potent, selective, orally active antagonist of the prostaglandin E2 receptor subtype 4 (EP4-R) against human EP4-R IC50 15.3 nM. BAY-1316957 has excellent drug metabolism and pharmacokinetic properties and can be used in the study of endometriosis. | ||
| M10795 | BGC-20-1531 free base | Prostaglandin Receptor |
| PGN 1531 free base | ||
| BGC-20-1531 (PGN 1531) free base is a potent selective prostaglandin EP4 receptor antagonists, pKB The value is 7.6. BGC-20-1531 free base has the potential to study migraines. | ||
| M10803 | Butaprost | Prostaglandin Receptor |
| Butaprost is a selective prostaglandin E receptor (EP2) agonist for murine EP2 receptors EC50 The value is 33 nM,Ki The value is 2.4 μM. Butaprost is less active against rodents EP1, EP3 and EP4 receptors. Butaprost mitigates fibrosis by obstructing TGF-β/Smad2 signaling. | ||
| M10807 | CJ-42794 | Prostaglandin Receptor |
| CJ-042794 | ||
| CJ-42794 is a selective prostaglandin receptor EP4 antagonist that inhibits [3H]-PGE2 binding to EP4 receptors with an average pKi of 8.5 and is more than 200 times more selective than EP1, EP2 and EP3. | ||
| M10827 | GSK726701A | Prostaglandin Receptor |
| GSK726701A is a partial agonist of prostaglandin E2 receptor 4 (EP4),pEC50is 7.4. | ||
| M10842 | KAG-308 | Prostaglandin Receptor |
| KAG-308 is an effective, selective, orallyable EP4 receptor (a subtype of prostaglandin E2 receptor) agonist that inhibits colitis, promotes tissue mucosal healing, and effectively inhibits the production of TNF-α. KAG-308 for human EP4 receptors Ki value and EC50 The values were 2.57 nM and 17 nM, respectively, which were more selective than EP1, EP2, EP3, and IP receptors. | ||
| M10856 | MF498 | Prostaglandin Receptor |
| MF498 is a novel selective prostaglandin E4 receptor (EP4 receptor) antagonist with a strong affinity with the EP4 receptor, with a Ki of 0.7 nM. | ||
| M15094 | Bromelain | Apoptosis |
| Bromelain, an anti-inflammatory compound derived from pineapple stem, acts by down-regulating plasma kinkinin, inhibiting prostaglandin E2 expression, degradation of receptors for advanced glycation end products, regulation of angiogenic biomarkers, and antioxidant activity upstream of the COX pathway. Can be used as a food additive. | ||
| M20392 | Bimatoprost | Prostaglandin Receptor |
| Bimatoprost is a synthetic prostaglandin analog as well as a prostaglandin F (FP) receptor agonist (FPA) with IOP-lowering activity for studies related to glaucoma and IOP. | ||
| M20536 | Setipiprant (ACT-129968, KYTH-105) | Immunology/Inflammation |
| Setipiprant(ACT-129968, KYTH-105) is a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2) that that has been shown to have greater specificity for DP2 (CRTH2) than for DP1. | ||
| M21029 | MRE-269 | Immunology/Inflammation |
| ACT-333679 | ||
| MRE-269 (ACT-333679) is a prostaglandin I2 (IP) receptor agonist with a binding affinity for the human IP receptor that is 130-fold greater than that for other human prostanoid receptor. | ||
| M21316 | BAY-6672 | Prostaglandin Receptor |
| BAY-6672 is a potent and selective human prostaglandin F (FP) receptor antagonist with an IC50 value of 11 nM. | ||
| M27952 | L-670596 | Prostaglandin Receptor |
| L-670596 is an orally active and selective thrombsxane A2 receptor/prostaglandin receptor antagonist. L-670596 inhibits arachidonic acid and U-44069 induced bronchoconstriction in the guinea pig. L-670596 also inhibits the aggregation of human platelet rich plasma induced by U-44069. | ||
| M28496 | SC 51089 | Prostaglandin Receptor |
| SC 51089 is a selective antagonist of prostaglandin E2 EP1 receptor, with Kis of 1.3, 11.2, 17.5, and 61.1 μM for EP1, TP, EP3, and FP receptors, respectively. SC 51089 exhibits neuroprotective activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
